These days, it hasn't been a hot stock to own, not by any stretch. Investors are worried about its growth. Its recent results ...

Pfizer (PFE) recently reported a revenue decline tied to weaker COVID product sales and a US$4.4b impairment charge, while ...

AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) both reported fourth quarter earnings in early February. AbbVie posted record net ...

Actress, producer, and artist Lucy Liu has joined Pfizer’s mission to deliver a knockout blow against cancer, becoming the ...

By Manya Saini April 17 (Reuters) - Weight-loss drug developer Kailera Therapeutics' shares surged 62.5% in their Nasdaq ...

Pfizer shows why a strong pipeline is so important.

The FDA has scolded Pfizer over Facebook ads for the cancer drug Adcetris, accusing the Big Pharma of failing to adequately ...

In an Untitled Letter, regulators said Facebook promotions for Pfizer’s lymphoma therapy overstated its approved use and ...

The results suggest the drug boasts similar safety and efficacy in non-small cell lung cancer compared with the field’s ...

Elon Musk this week amplified an unfounded claim, based on a distortion of vaccine safety monitoring data, that COVID-19 ...

The choice is based on more than just the dividend payout.

Storm Therapeutics has closed a $56 million series C financing as the British biotech kicks off a phase 2 sarcoma trial of ...